Results 1 - 10 of 23 for Pomalidomide "CC-4047"
  1. Pomalidomide 
    Pomalidomide is used in combination with dexamethasone to treat multiple myeloma (a type of cancer of the ... do not have human immunodeficiency virus (HIV) infection. Pomalidomide is in a class of medications called immunomodulatory ...
    https://medlineplus.gov/druginfo/meds/a613030.html - Drugs and Supplements
  2. Pomalidomide Plus Low-Dose Dexamethasone Improves Survival for Patients with Multiple Myeloma From the National Institutes of Health (National Cancer Institute)  
    ... phase III trial that compared the combination of pomalidomide (Pomalyst®) and low-dose dexamethasone versus high-dose ...
    https://www.cancer.gov/.../research/pomalidomide-dexamethasone - External Health Links
  3. Elotuzumab Injection 
    ... with lenalidomide (Revlimid) and dexamethasone or along with pomalidomide (Pomalyst) and dexamethasone to treat multiple myeloma (a ... every 2 weeks. When used in combination with pomalidomide and dexamethasone it is usually given once a ...
    https://medlineplus.gov/druginfo/meds/a616001.html - Drugs and Supplements
  4. Isatuximab-irfc Injection 
    Isatuximab-irfc injection is used along with pomalidomide (Pomalyst) and dexamethasone to treat multiple myeloma (a type of cancer of the bone marrow) in adults who have received at least two ...
    https://medlineplus.gov/druginfo/meds/a620023.html - Drugs and Supplements
  5. Primary Myelofibrosis From the National Institutes of Health (National Cancer Institute)  
    Chronic myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, ...
    https://www.cancer.gov/.../chronic-treatment-pdq#section/_234 - External Health Links
  6. Chronic Myeloproliferative Neoplasms Treatment From the National Institutes of Health (National Cancer Institute)  
    Chronic myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, ...
    https://www.cancer.gov/.../chronic-treatment-pdq#section/_258 - External Health Links
  7. Treatment Options for Chronic Myeloproliferative Neoplasms From the National Institutes of Health (National Cancer Institute)  
    Chronic myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, ...
    https://www.cancer.gov/.../chronic-treatment-pdq#section/_288 - External Health Links
  8. Treatment Option Overview (Chronic Myeloproliferative Neoplasms) From the National Institutes of Health (National Cancer Institute)  
    Chronic myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, ...
    https://www.cancer.gov/.../patient/chronic-treatment-pdq#section/_28 - External Health Links
  9. Essential Thrombocythemia From the National Institutes of Health (National Cancer Institute)  
    Chronic myeloproliferative neoplasms treatments vary and depend upon the specific diagnosis. Treatment may include observation, phlebotomy, transfusions, ...
    https://www.cancer.gov/.../chronic-treatment-pdq#section/_245 - External Health Links
  10. Treatment Option Overview (Plasma Cell Neoplasms Including Multiple Myeloma) From the National Institutes of Health (National Cancer Institute)  
    Treatment of plasma cell neoplasms (including multiple myeloma, monoclonal gammopathy of undetermined significance, and plasmacytoma) includes observation, ...
    https://www.cancer.gov/.../patient/myeloma-treatment-pdq#section/_46 - External Health Links
previous · 1 · 2 · 3 · next